chr7-142252600-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001001317.5(PRSS58):c.448G>A(p.Asp150Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000364 in 1,611,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001317.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRSS58 | ENST00000547058.6 | c.448G>A | p.Asp150Asn | missense_variant | Exon 5 of 6 | 1 | NM_001001317.5 | ENSP00000447588.2 | ||
PRSS58 | ENST00000552471.1 | c.448G>A | p.Asp150Asn | missense_variant | Exon 4 of 5 | 2 | ENSP00000446916.1 | |||
ENSG00000241881 | ENST00000486508.2 | n.254+3817C>T | intron_variant | Intron 1 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152106Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000229 AC: 57AN: 248552 AF XY: 0.000171 show subpopulations
GnomAD4 exome AF: 0.000370 AC: 540AN: 1459398Hom.: 0 Cov.: 33 AF XY: 0.000331 AC XY: 240AN XY: 725806 show subpopulations
GnomAD4 genome AF: 0.000302 AC: 46AN: 152106Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74300 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.448G>A (p.D150N) alteration is located in exon 5 (coding exon 4) of the PRSS58 gene. This alteration results from a G to A substitution at nucleotide position 448, causing the aspartic acid (D) at amino acid position 150 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at